HOSPITALS
JENNIFER JONES-MCMEANS
ADVANCING HEALTH EQUIT Y WITH ABBOTT
Underrepresentation in clinical trials is creating health inequity that Jennifer Jones-McMeans is determined to dismantle at Abbott
WRITTEN BY : HELEN ADAMS
As we get older , our quality of life tends to decline , but that ’ s no need for our healthcare standards to decline , too . While not a hard-and-fast rule of getting older , ageing bodies experience an increasing range of issues , meaning that medical care for issues such as high cholesterol and blood pressure , cardiovascular events , joint pain , and agerelated mental deterioration becomes more commonplace in the latter stages of life .
Global healthcare leader Abbott helps people live life to the fullest – whatever stage you ’ re in . As Abbott ’ s divisional Vice President of Global Clinical Affairs for the healthcare company ’ s vascular arm , Jennifer
Jones-McMeans is part of a team of 113,000 employees working across 160 countries .
She ’ s located in San Francisco ’ s Bay Area and boasts notable qualifications and experience for her role : a Doctorate in exercise physiology from the University of Maryland College Park ; a three-year post-Doctoral Fellowship in the Division of Hypertension at the University of Texas Southwestern Medical Centre ; and , while undergoing her fellowship , Jones-McMeans conducted clinical trials for hypertension and cardiovascular disease , taking part in community-based research that sought to educate local community leaders .
42 September 2022